Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Preceptorship on Non-Small-Cell Lung Cancer 2019: Singapore

ESMO Preceptorship on NSCLC Singapore 2019 banner
Start date
20 Nov 2019
End date
21 Nov 2019
Location
Republic of Singapore

Learning objectives

  • To learn about best clinical practice in the management of Non-Small-Cell Lung Cancer (NSCLC) in the adjuvant, locally advanced and metastatic setting
  • To understand the importance of pathology and histoprognostic factors in the management of NSCLC
  • To learn about the management of patients after progression, side effects of treatments and the use of targeted agents in NSCLC

Download the programme

Accreditation

The programme of this event has been accredited with 11 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

  • David Planchard, France
  • Ross A. Soo, Singapore

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.